Market Place
Sourcing Support
Aspire Biopharma starts Phase 1 trial for high-dose Aspirin
20 May 2025 //
ACCESSWIRE
Aspire Biopharma to Present at Sidoti Virtual Investor Conference
08 May 2025 //
ACCESSWIRE
Aspire Biopharma to Present at Emerging Growth Conference on April
14 Apr 2025 //
ACCESSWIRE
Aspire Biopharma begins producing pre-workout Supplement
11 Apr 2025 //
ACCESSWIRE
Aspire Biopharma Provides an Update on Lead Product Candidate
25 Feb 2025 //
ACCESSWIRE
Aspire Biopharma Holdings Announce Public Listing on Nasdaq
20 Feb 2025 //
ACCESSWIRE
Aspire Biopharma Signs Securities Purchase Agreement
20 Feb 2025 //
ACCESSWIRE
Aspire Biopharma Announces Public Listing on Nasdaq
19 Feb 2025 //
ACCESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.